Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tarnow

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2007
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up studyA S Astrup, L Tarnow, M Christiansen, et al.
Diabetes|December 1, 1995
Low birth weight. A risk factor for development of diabetic nephropathy?P Rossing, L Tarnow, F S Nielsen, et al.
Kidney International|August 1, 1996
Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathyH P Hansen, P Rossing, L Tarnow, et al.
Kidney International|June 1, 1995
Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathyH P Hansen, P Rossing, L Tarnow, et al.
Ugeskrift for Laeger|December 30, 1996
[Low birth weight--increased risk of diabetic nephropathies?]P Rossing, L Tarnow, F S Nielsen, et al.
Kidney International|June 16, 2006
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathyK J Schjoedt, K Rossing, T R Juhl, et al.
Diabetes|May 4, 2001
Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patientsO Poirier, V Nicaud, N Vionnet, et al.
Diabetes Care|May 20, 1998
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patientsF S Nielsen, A Sato, S Ali, et al.
Kidney International|April 29, 1998
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathyP Jacobsen, K Rossing, P Rossing, et al.
Diabetes Care|March 31, 1999
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up studyH H Parving, L Tarnow, F S Nielsen, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2007
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up studyA S Astrup, L Tarnow, M Christiansen, et al.
Diabetes|December 1, 1995
Low birth weight. A risk factor for development of diabetic nephropathy?P Rossing, L Tarnow, F S Nielsen, et al.
Kidney International|August 1, 1996
Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathyH P Hansen, P Rossing, L Tarnow, et al.
Kidney International|June 1, 1995
Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathyH P Hansen, P Rossing, L Tarnow, et al.
Ugeskrift for Laeger|December 30, 1996
[Low birth weight--increased risk of diabetic nephropathies?]P Rossing, L Tarnow, F S Nielsen, et al.
Kidney International|June 16, 2006
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathyK J Schjoedt, K Rossing, T R Juhl, et al.
Diabetes|May 4, 2001
Polymorphism screening of four genes encoding advanced glycation end-product putative receptors. Association study with nephropathy in type 1 diabetic patientsO Poirier, V Nicaud, N Vionnet, et al.
Diabetes Care|May 20, 1998
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patientsF S Nielsen, A Sato, S Ali, et al.
Kidney International|April 29, 1998
Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathyP Jacobsen, K Rossing, P Rossing, et al.
Diabetes Care|March 31, 1999
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up studyH H Parving, L Tarnow, F S Nielsen, et al.
Pageof 11